The results showed that the level of cytl1 expression was significantly lower in tumor tissues than in adjacent nontumor tissues in breast cancer patients based on data obtained from The Cancer Genome Atlas (TCGA) database (Fig. 1a). The gene discussed is CYTL1; the disease is neoplasm.